Wednesday, January 16, 2019
Understanding the Burden and Risks of Peanut Allergy
David Stukus, MD
Associate Professor of Pediatrics, Division of Allergy and Immunology
Nationwide Children’s Hospital, Ohio State University College of Medicine

David Stukus, MD

Manish Butte, MD, PhD
David Geffen School of Medicine, UCLA

Bradley Chipps, MD
Capital Allergy Respiratory Disease Center, Sacramento

Jonathan Corren, MD
Ronald Reagan UCLA Medical Center

Gailen Marshall, MD, PhD
University of Mississippi Medical Center

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Exhibitors
Abbott Laboratories, Accredo Health, ALK, AstraZeneca, BMR Partners, Circassia, CSL Behring, Diplomat Specialty Infusion, Genentech-Novartis, GlaxoSmithKline, Respiratory Biologics Division, Inventive Health, IV League Pharmacy, IV Med Services, Jubilant Hollister-Stier, Kaleo, Lincoln Diagnostics, Inc., Merck, Mylan Specialty, Novartis Pharmaceuticals, NuFactor/FFF Enterprises, Nutricia, Octapharma, Optinose, Pfizer, Rabbit Air, Sanofi/Genzyme and Regeneron, Shire- Hereditary Angioedema, Shire- Primary Immunodeficiency, Stallergenes Greer, TEVA Pharmaceuticals, and US Bioservices-Amerisource Bergen.

Wednesday, January 17, 2018
Novel Insights in Atopic Dermatitis
Jonathan Spergel, MD
Professor of Pediatrics
Children’s Hospital of Philadelphia, Perelman School of Medicine, Univ. of Pennsylvania

Jonathan Spergel, MD

From left to right- Marilyn Li, MD, LASAACI 2017 President, and Gary Gibbon, MD, LASAACI 2018 President

Wednesday, January 18, 2017
Chronic Idiopathic Urticaria
Philip Lieberman, MD
Clinical Professor of Medicine and Pediatrics
University of Tennessee College of Medicine

Philip Lieberman, MD

From left to right- LanAnh Do, MD, LASAACI 2016 President, and Marilyn Li, MD, LASAACI 2017 President

William Busse, MD
University of Wisconsin, Madison

Joseph Fowler, MD
University of Louisville, Kentucky

Alan Goldsobel, MD
Allergy and Asthma Associates of No. CA

Susan Lynch, PhD
UC San Francisco

Left to right: Joseph Fowler, MD, University of Louisville; Alan Goldsobel, MD, UC San Francisco; LanAnh Do, MD, LASAACI President; Susan Lynch, MD, UC San Francisco; and William Busse, MD, University of Wisconsin Medical School.

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Exhibitors
Abbott Laboratories, Accredo Health, Alcon Laboratories, AstraZeneca, Baxalta, Biofusion, BioRx, Bioscrip, Boehringer-Ingelheim, Boston Scientific, Circassia, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Grifols, Hollister-Stier, Horizon Pharma, Infusion for Health, Integrated Care Systems, IV League Pharmacy, Kabafusion, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mylan Specialty, Novartis Pharmaceuticals, Novartis, NuFactor/FFF Enterprises, Rabbit Air, Shire, and TEVA Pharmaceuticals.

“Chronic Idiopathic Urticaria”
Allen Kaplan, MD
Clinical Professor of Medicine,
Medical University of South Carolina

Allen Kaplan, MD

From left to right- LanAnh Do, MD, LASAACI 2016 President, and Margaret Kurohara, MD, LASAACI 2015 President

Management of Patients with Multiple Drug Allergies
Aleena Banerji, MD
Harvard Medical School
Massachusetts General Hospital

New Treatment Modalities for Atopic Dermatitis
Mark Boguniewicz, MD
National Jewish Medical and Research Center

Role of Infection in Severe Asthmatics
James Gern, MD
University of Wisconsin, Madison

New Advances in the Treatment of Food Allergies
Anna Nowak-Wegrzyn, MD
Mount Sinai Hospital and Medical Center

Left to right: Mark Boguniewicz, MD, Margaret Kurohara, MD, LASAACI President, Anna Nowak-Wegrzyn, MD,
Aleena Banerji, MD, and James Gern, MD

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Merck provided an Educational Grant.

Exhibitors:
Abbott Laboratories, Accredo Health Inc., Aerocrine, Inc., Alcon Laboratories, Inc., AstraZeneca LP, Baxalta Bioscience, Bio Products Laboratory (BPL), Boehringer-Ingelheim, Boston Scientific, Coram, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Grifols Bioscience, Horizon Pharma, IV League Pharmacy, Jubilant Hollister-Stier, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mylan Specialty, Novartis Pharmaceuticals, Novartis (Inflammatory Disease Division), NuFactor/FFF Enterprises, PuraCap, Rabbit Air, Sanofi, Shire (Specialty Pharmaceuticals), Shire (Rare Diseases Unit), Soleo, TEVA Pharmaceuticals, and Walgreens Infusion Services.

“Chronic Urticaria:
Optimizing Treatment in Challenging Cases”
Richard Gower, MD
Clinical Associate Professor of Medicine,
University of Washington, School of Medicine.

Richard Gower, MD

From left to right- William Crawford, MD, LASAACI 2014 President, and Margaret Kurohara, MD, LASAACI 2015 President.

Impact of Vitamin D on Asthma
Michael B. Foggs, MD

Adult Onset Primary Immunodeficiency: What’s New in the Old
Steven M. Holland, MD

Alternative Medicine: Sense and Nonsense
Paul A. Offit, MD

Urticaria, Pathogenesis
Bruce L. Zuraw, MD

Left to right: Bruce Zuraw, MD, Steven Holland, MD, William Crawford, MD, LASAACI President, Michael Foggs, MD, and Paul Offit, MD

Caroline Caperton, MD, Allergy Fellow, UC Irvine

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

AstraZeneca, Grifols, and the AAAAI (Urticaria grant) provided Educational Grants.

Exhibitors
Abbott Laboratories, Accredo Health Inc., Aerocrine, Inc., Alcon Laboratories, Inc., AstraZeneca LP, Baxter Bioscience, Bio Products Laboratory (BPL), BioRx LLC, Bioscrip, Boston Scientific, Coram, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Grifols Bioscience, IV League Pharmacy, Jubilant Hollister-Stier Laboratories, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mylan Specialty, NeilMed Pharmaceuticals, Inc., Novartis Pharmaceuticals, Novartis (Inflammatory Disease Division), NuFactor/FFF Enterprises, Rabbit Air, Sanofi, Shire (Specialty Pharmaceuticals), Shire (Rare Diseases Unit), TEVA Pharmaceuticals, US Bioservices, and Walgreens Infusion Services.

“Shifting Paradigms in Hereditary Angioedema:
A Focus on Prophylaxis”
Marc Riedl, MD
Associate Professor of Medicine and Clinical Director
of the US HAEA Angioedema Center at UC San Diego.

Marc Riedl, MD

From left to right- Catherine Fuller, MD, LASAACI 2013 President, and William Crawford, MD, LASAACI 2014 President

Mast Cell Activation Syndromes: From Mastocytosis to Anaphylaxis
Mariana Castells, MD, PhD

Asthma Phenotypes: The Evolution from Clinical To Molecular
Sally Wenzel, MD

What is New in Immunoglobulin Therapy?
E. Richard Stiehm, MD

Lessons We Have Learned from Clinical Trial Design for Sublingual Immunotherapy
Peter Socrates Creticos, MD

Left to right: Catherine Fuller, MD, LASAACI President, Sally Wenzel, MD, Mariana Castells, MD, PhD, and E. Richard Stiehm, MD

Left to right: Alan Khadavi, MD, and Jennifer Overman, Jubilant Hollister-Stier

Left to right: Mariana Castells, MD, PhD, and Peter S. Creticos, MD

Left to right: Susan Jene Kim, MD, and Angela Crans-Yoon, MD

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

AstraZeneca, Merck, Mylan Specialty, and Sunovion provided Educational Grants

Exhibitors
Abbott Laboratories, Accredo Health Inc., Aerocrine, Inc., Alcon Laboratories, Inc., ALK Abello, AstraZeneca LP, Baxter Bioscience, Bio Products Laboratory (BPL), BioRx LLC, Bioscrip, Boston Scientific, CSL Behring, Dyax,Genentech, GlaxoSmithKline, Grifols Bioscience, IV League Pharmacy, Jubilant Hollister-Stier Laboratories LLC,LifeCare Solutions, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mission Allergy, Mylan Specialty, NeilMed Pharmaceuticals, Inc., Novartis Pharmaceuticals, NuFactor/FFF Enterprises, Octapharma, Rabbit Air, Sanofi, Shire Human Genetic Therapies, Sunovion, TEVA Pharmaceuticals, Thayer Medical, Thermo Fisher Scientific, US Bioservices, ViroPharma Incorporated, and Walgreens Infusion Services.

“Airways and Inflammation- Improving the Management of Patients with Asthma”
Stephen P. Peters, MD, PhD
Professor of Internal Medicine, Pediatics, and Translational Science
Wake Forest University School of Medicine
Winston-Salem, North Carolina

From left to right- Stephen P. Peters, MD, PhD and Catherine Fuller, MD, LASAACI 2013 President

From left to right- Margaret Kurohara, MD, LASAACI Board, Catherine Fuller, MD, LASAACI 2013 President, and Joe Shapiro, LASAACI 2012 President

Aspirin Exacerbated Respiratory Disease:
New Molecular Insights into an Old Mystery
Joshua Boyce, MD

Food Allergy Diagnostics: New Guidelines and Beyond
Scott H. Sicherer, MD

Refractory Urticaria
David Khan, MD

Human Biome and Immune Development:
Influences on Natural Selection and the “Hygiene Hypothesis”
Larry Borish, MD

Left to right: Joseph Shapiro, MD, LASAACI President, Scott Sicherer, MD, Larry Borish, MD and Joshua Boyce, MD

Left to right: Dave Khan, MD, and Joseph Shapiro, MD, LASAACI President

Left to right: Teva Respiratory-Robert Chang, Jehan Huleisy, and Mike Fish

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Abbott Nutrition and Mylan Specialty provided Educational Grants

Exhibitors
Abbott Laboratories, Accredo Health Inc., Aerocrine, Inc., Alcon Laboratories, Inc., ALK Abello, Allermed Laboratories, AstraZeneca LP, Baxter Bioscience, Biofusion, Bio Products Laboratory (BPL), BioRx LLC, Boston Scientific, Coram, Inc., CSL Behring, LLC, Dyax, Grifols Bioscience, Jubilee Hollister-Stier Laboratories LLC, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mission Allergy, Mylan Specialty, NeilMed Pharmaceuticals, Inc., Novartis Pharmaceuticals, NuFactor/FFF Enterprises, Nutricia North America, Inc., Octapharma, Oso Home Health Care, Inc., Shire Human Genetic Therapies, Sunovion, TEVA Pharmaceuticals, Thermo Fisher Scientific, US Bioservices, ViroPharma Incorporated, and Walgreens/Crescent Healthcare.

“Optimizing Asthma Care”
Richard J. Martin, MD
Chairman and Professor of Medicine
National Jewish Hospital, Denver, Colorado

From left to right- Joseph Shapiro, MD, LASAACI 2012 President, Richard J. Martin, MD, and Ricardo Tan, MD, LASAACI 2011 President

From left to right: Ricardo Tan, MD, LASAACI President, Donald Leung, MD, Dana Wallace, MD and Jonathan Spergel, MD

From left to right: Jonathan Spergel, MD, Charlotte Cunningham-Rundles, MD, and Marc Riedl, MD, LASAACI Board

Program Agenda:

• Update on Diagnosis and Management of Antibody Deficiencies
  Charlotte Cunningham-Rundles, MD, PhD
   
• Update on Atopic Dermatitis
  Donald Leung, MD
   
• Eosinophilic Gastrointestinal Disorders
  Jonathan Spergel, MD, PhD
   
• Asthma vs. COPD: A Clinical Diagnosis
  Dana Wallace, MD

From left to right: Tracey Bruckner, from Johnson & Johnson/McNeil and Neil Ross, from Biofusion.

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Abbott Laboratories, Aerocrine, Inc., Alcon Laboratories, Inc., ALK Abello, Allermed Laboratories, AstraZeneca LP, Baxter Bioscience, BioRx, Biofusion, Coram, Crescent Home Health, CSL Behring, LLC, Dey LP, Dyax, Genentech, GlaxoSmithKline, Greer, Grisfols Bioscience, Hollister-Stier Laboratories, Johnson & Johnson/McNeil, Kedrion, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, NeilMed Pharmaceuticals, Inc., Novartis, Nutricia North America, Inc., Shire Human Genetic Therapies, South Coast Air Quality Management District, Sunovion, TEVA Respiratory, LLC, Thermo Fisher Scientific, US Bioservices, and ViroPharma Incorporated.

“Health Care Reform and Its Impact on the Practicing Allergist”
James L. Sublett, MD, President, Joint Council of Allery, Asthma & Immunology

From left to right- James Sublett, MD, and Ricardo Tan, MD, LASAACI President

Fall 2010 Symposium
From left to right: Harold Nelson, MD, Bob Lanier, MD, Michael Kaliner, MD, and Wesley Burks, MD.

Program Agenda:

• Non Allergic Rhinopathy
  Michael Kaliner, MD
   
• New Developments in the Long-Acting Beta-Agonist Safety Controversy
  Harold Nelson, MD
   
• Global Warming- Straight Talk From A Skeptic
  Bob Lanier, MD
   
• Food Allergy- Why Are All These Families Going Nuts?
  Wesley Burks, MD

Fall 2010 Symposium
From left to right: Heidi Shadravan and Darnell Wyrick from Sanofi Aventis.

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Abbott Laboratories Aerocrine, Inc., Alcon Laboratories, Inc., ALK Abello, Allermed Laboratories, AstraZeneca LP, Baxter Bioscience, BioRx, Bioscrip, Biofusion, Boehringer Ingelheim Pharmaceuticals, Inc. Coram, Crescent Home Health, CSL Behring, LLC, Dey LP, Dyax, Genentech, GlaxoSmithKline, Greer, Grisfols Bioscience, Johnson & Johnson/McNeil, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mission Allergy, NeilMed Pharmaceuticals, Inc., Novartis, Nutricia North America, Inc., Octapharma, Phadia US Inc., Rabbit Air, Sanofi-Aventis, Sepracor, Shire Human Genetic Therapies, South Coast Air Quality Management District, Talecris Biotherapeutics, TEVA Respiratory, LLC, UCB, Inc., UCLA Food and Drug Allergy Care Center, US Bioservices, and ViroPharma Incorporated.

“Asthma Control- Treating Inflammation in Both the Large and Small Airways”
Brian J. Lipworth, MD, FRCP, FACAAI
Dr. Lipworth is a Professor of Allergy and Respiratory Medicine at Ninewells Hospital and Medical School in Dundee, University of Dundee, Scotland, United Kingdom. Honorary Professor of Medical Science, University of St. Andrews.

From left to right: Brian Lipworth, MD and Alan Szeftel, MD, LASAACI President

Program agenda included:

“Immune Response Modifiers in the Treatment of Allergic Diseases”
Mark Ballow, MD, State University of New York at Buffalo

“Asthma Masquerader”
Fernando J. Martinez, MD University of Michigan Health System

�Allergic Conjunctivitis” and “Chronic Rhinosinusitis and Nasal Polyposis”
Thomas B. Casale, MD, Creighton University Medical Center

�ABAI Maintenance of Certification for the Allergist for 2010 and Beyond�
Mark L. Corbett, MD, ABAI Maintenance of Certification Task Force

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Abbott Laboratories, Aerocrine, Inc., Alcon Laboratories, Inc., Allermed Laboratories, Apieron, Inc., Asthma & Allergy Foundation of America, California Chapter, AstraZeneca LP, Baxter Bioscience, Bioscrip, Biofusion, Crescent Home Health, CSL Behring, LLC, Dey LP, Genentech, GlaxoSmithKline, Greer, Hollister-Stier Laboratories LLC, IBT Laboratories, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mission Allergy, NeilMed Pharmaceuticals, Inc., Novartis, Nutricia North America, Inc., Octapharma, Sanofi-Aventis, Schering Plough, Sciele Pharma, Inc., Shier Human Genetic Therapies, South Coast Air Quality Management District, Talecris Biotherapeutics, TEVA Respiratory, LLC, UCB, Inc., US Bioservices, and ViroPharma Incorporated.

“Exhaled Nitric Oxide: Its Role in Managing Asthma”
Speaker: Phillip Korenblat, MD
Professor of Internal Medicine
Division of Allergy and Immunology
Washington University School of Medicine in St. Louis

From left to right – Phillip Korenblat, MD and Joseph Shapiro, MD, LASAACI Treasurer

From left to right – Jacob Offenberger, MD, LASAACI 2008 President accepts award plaque from Charles Song, MD, LASAACI 2009 President.

The program agenda included:

The Expanding Roles of Respiratory Infections in Asthma
William Busse, MD
University of Wisconsin School of Medicine and Public Health, Department of Medicine.

Health Effects of Indoor Dampness
Peyton Eggleston, MD
Johns Hopkins School of Medicine, Department of Pediatrics.

Inherited and Other Types of Angioedema: Current Status
Michael Frank, MD
Duke University School of Medicine, Pediatrics, Allergy and Immunology.

Pediatric Sinusitis- Medical vs. Surgical Management
Matthew Ryan, MD,
University of Texas, Southwestern Medical School

Many thanks to the Pharmaceutical companies that sponsored the Fall Symposium:

Aerocrine, Inc., Air Quality Management District, Alcon Laboratories, Inc., ALK Abello, Inc., Allermed Laboratories, Apieron, Inc., AstraZeneca, Bioscrip, Biofusion, Boehringer Ingelheim Pharmaceuticals, Inc., CSL Behring, LLC, Dey LP, Genentech, GlaxoSmithKline, Graceway Pharmaceuticals, Greer, Hollister-Stier Laboratories, LLC, IBT Laboratories, Jerini US, Inc., Johnson & Johnson, Lev Pharmaceuticals, Inc., Lincoln Diagnostics, Meda Pharmaceuticals, Merck, Mission Allergy, NeilMed Pharmaceuticals Inc., Novartis, Nutricia North America, Inc., Reckitt Benckiser, Sanofi-Aventis, Schering Plough, Sciele Pharma, Inc., Sepracor, TEVA Pharmaceuticals, and UCB, Inc

Left- Lynn Harvey, M.S., GlaxoSmithKline, Senior Market Development Manager, and Joseph Spahn, MD, National Jewish Medical and Research Center. GlaxoSmithKline sponsored the meeting and Dr. Spahn addressed the members on the New NAEPP Guidelines. Over 60 LASAACI members attended the meeting.

Left- Jacob Offenberger, MD, 2008 LASAACI President presenting award plaque to Joseph Dizon, MD, 2007 LASAACI President.

LanAnh Do, MD (center), LASAACI Board Member and others enjoy the presentation by Joseph Spahn, MD.
 

The September 29, 2007 Fall Symposium program agenda included:

New Tools for Assessing Asthma Control
Andrew Liu, MD, Associate Professor
National Jewish Medical and Research Center

Drug Allergy
Timothy J. Sullivan, MD, Clinical Associate Professor
Department of Pediatrics, Medical College of Georgia

Food Allergy Sensitization and Provocation by Skin Contact
Sami Bahna, MD, Professor of Pediatrics and Medicine
Louisiana State University School of Medicine

Efficacy of Sublingual Immunotherapy
Linda Cox, MD
Private Practice, Fort Lauderdale, Florida

Left to right- Robert Eitches, MD, Peggy Goldenhersh, MD, Roger Katz, MD, and Charles Song, MD, background on the right. LASAACI members attended a free EMR Workshop on June 14, 2008. Four companies demonstrated their products.